| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.09B | 26.32B | 25.96B | 26.73B | 23.12B | 18.07B |
| Gross Profit | 4.36B | 4.31B | 3.63B | 3.65B | 2.80B | 2.65B |
| EBITDA | 2.90B | 2.83B | 2.39B | 2.35B | 1.58B | 1.90B |
| Net Income | 966.00M | 798.00M | 538.00M | 466.00M | 43.00M | 285.00M |
Balance Sheet | ||||||
| Total Assets | 33.61B | 33.71B | 35.27B | 32.71B | 31.47B | 27.81B |
| Cash, Cash Equivalents and Short-Term Investments | 2.98B | 3.17B | 2.64B | 2.10B | 3.12B | 2.60B |
| Total Debt | 9.43B | 9.12B | 12.02B | 9.53B | 9.19B | 7.74B |
| Total Liabilities | 15.95B | 15.66B | 18.43B | 17.67B | 17.68B | 14.55B |
| Stockholders Equity | 14.12B | 14.36B | 13.52B | 11.82B | 11.04B | 10.80B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.76B | -1.29B | -1.30B | -518.00M | 1.00B |
| Operating Cash Flow | 0.00 | 4.81B | -53.00M | -119.00M | 1.03B | 2.09B |
| Investing Cash Flow | 0.00 | -1.03B | -1.62B | -1.15B | -1.55B | -1.10B |
| Financing Cash Flow | 0.00 | -3.29B | 2.20B | 238.00M | 1.02B | -510.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥11.45B | 7.66 | ― | 3.48% | 0.24% | 20.23% | |
76 Outperform | ¥5.27B | 15.34 | ― | 4.79% | -0.27% | 59.50% | |
72 Outperform | ¥15.72B | 4.33 | ― | 2.87% | 2.38% | -5.80% | |
69 Neutral | ¥6.70B | -102.51 | ― | 1.06% | 6.41% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
54 Neutral | ¥21.07B | 3.53 | ― | 4.33% | 5.12% | ― | |
51 Neutral | ¥10.37B | -20.41 | ― | 0.11% | -10.82% | -69.03% |